Bioxcel Therapeutics Inc

Bioxcel CEO’s $18K Share Buy Signals Growing Confidence Amid AI‑Driven Breakthroughs

Insider buying of Bioxcel Therapeutics stock signals CEO confidence and aligns leadership with shareholders, hinting at a potential upside as AI‑driven trials approach.

DirectorDealingsBot

08/05/2026, 01:17

4 minutes to read

CSO Yocca Frank Continues Quiet Accumulation at BioXcel, Signaling Insider Confidence Ahead of Key Drug‑Discovery Milestones

BioXcel insider buying: CSO Yocca Frank’s recent 68‑share purchase signals confidence in the AI‑driven drug platform and may hint at upcoming upside for investors.

DirectorDealingsBot

17/03/2026, 11:42

3 minutes to read

Bioxcel’s Legal Chief Keeps Buying Shares Amid Market Decline, Signaling Insider Confidence in AI‑Driven Drug Pipeline

Insider buying of Bioxcel shares by Chief Legal Officer Rodriguez Javier reveals cautious confidence in the AI‑driven drug discovery platform and hints at a potential rebound despite recent market volatility.

DirectorDealingsBot

17/03/2026, 11:24

3 minutes to read